Lily Indriani Octovia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lily Indriani Octovia has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aditya Wardhana
Burn and Wound Care Division, Department of Plastic Surgery and Reconstructive Surgery, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta 10430, Indonesia
2 shared publications - Nurul Ratna Mutu Manikam
Department of Nutrition, Faculty of Medicine, Universitas Indonesia, dr. Cipto Mangunkusumo General Hospital. Jakarta, Indonesia
2 shared publications - Wina Sinaga
Department of Nutrition, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
2 shared publications Aditya Wardhana
Burn Unit, Division of Plastic Surgery, dr. Cipto Mangunkusumo National Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
1 shared publication- Akhmad Noviandi Syarif
Plastic Reconstructive and Aesthetic Division, Department of Surgery, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia
1 shared publication Alifa Nisa Deliyana
Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-14
Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review
Obesity remains a major global public health challenge associated with increased morbidity, mortality, and reduced quality of life, necessitating effective treatment strategies beyond lifestyle modifications. The present scoping review aimed to synthesize recent evidence on the effectiveness and safety of anti-obesity medications (AOMs). A structured literature search was conducted in PubMed and Scopus in May 2025 to identify original studies published within the previous five years involving individuals with overweight or obesity receiving pharmacological interventions. A total of 42 articles representing 41 unique studies, predominantly randomized controlled trials (RCTs), were included in the evidence synthesis. The review encompassed glucagon-like peptide-1 receptor agonists (GLP-1 RA), including semaglutide, liraglutide, exenatide, and orforglipron; multi-receptor incretin agonists, including tirzepatide, retatrutide, and survodutide; amylin-based combination therapy (cagrilintide plus semaglutide); established non-incretin AOMs (orlistat, phentermine, phentermine/topiramate, and naltrexone/bupropion); microbiome-targeted therapies; and nutraceutical-based interventions. Among these, GLP-1 RA consistently demonstrated substantial weight-loss efficacy, with semaglutide achieving approximately 10– 16% weight loss, while tirzepatide produced approximately 15– 21% weight reduction over treatment durations of 20– 70 weeks. Emerging multi-receptor incretin agonists also demonstrated promising efficacy, whereas established non-incretin AOMs, microbiome-targeted therapies, and nutraceutical-based interventions generally produced modest or more heterogeneous outcomes. Gastrointestinal adverse events (AEs) were the most frequently reported across incretin-based therapies. Overall, incretin-based therapies currently provide the greatest weight-loss benefit, although evidence for several emerging pharmacotherapies, microbiome-targeted therapies, and nutraceutical-based interventions remains limited. Further well-designed comparative trials, mechanistic studies, and long-term real-world investigations are needed to better establish the durability, safety, and clinical applicability of emerging AOMs.
- 1 September 2026
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-14
Open AccessRecent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review
Obesity remains a major global public health challenge associated with increased morbidity, mortality, and reduced quality of life, necessitating effective treatment strategies beyond lifestyle modifications. The present scoping review aimed to synthesize recent evidence on the effectiveness and safety of anti-obesity medications (AOMs). A structured literature search was conducted in PubMed and Scopus in May 2025 to identify original studies published within the previous five years involving individuals with overweight or obesity receiving pharmacological interventions. A total of 42 articles representing 41 unique studies, predominantly randomized controlled trials (RCTs), were included in the evidence synthesis. The review encompassed glucagon-like peptide-1 receptor agonists (GLP-1 RA), including semaglutide, liraglutide, exenatide, and orforglipron; multi-receptor incretin agonists, including tirzepatide, retatrutide, and survodutide; amylin-based combination therapy (cagrilintide plus semaglutide); established non-incretin AOMs (orlistat, phentermine, phentermine/topiramate, and naltrexone/bupropion); microbiome-targeted therapies; and nutraceutical-based interventions. Among these, GLP-1 RA consistently demonstrated substantial weight-loss efficacy, with semaglutide achieving approximately 10– 16% weight loss, while tirzepatide produced approximately 15– 21% weight reduction over treatment durations of 20– 70 weeks. Emerging multi-receptor incretin agonists also demonstrated promising efficacy, whereas established non-incretin AOMs, microbiome-targeted therapies, and nutraceutical-based interventions generally produced modest or more heterogeneous outcomes. Gastrointestinal adverse events (AEs) were the most frequently reported across incretin-based therapies. Overall, incretin-based therapies currently provide the greatest weight-loss benefit, although evidence for several emerging pharmacotherapies, microbiome-targeted therapies, and nutraceutical-based interventions remains limited. Further well-designed comparative trials, mechanistic studies, and long-term real-world investigations are needed to better establish the durability, safety, and clinical applicability of emerging AOMs.
- Open Access
- 11 December 2024
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 9 (2) , 42-47
Increased Nutrition Intake from Day 1 to Day 7 and Its Correlation with LOS in The Burn Unit of Dr. Cipto Mangunkusumo Hospital Jakarta
Introduction : Burn patients as well as the critically ill experience strong oxidative stress, an intense inflammatory response, and a prolonged months-long hypermetabolic and catabolic response that affect nutritional requirements. This study aimed to investigate the nutrition intake in the acute phase from day 1 to day 7 and the correlation with length of stay (LOS) in burn patients in Dr. Cipto Mangunkusumo General Hospital.Method : This cross-sectional study was conducted from January to December 2020 in the Burn Unit of Dr. Cipto Mangunkusumo General Hospital. Research subjects were burns patients who were willing to take part in this research and met the research criteria. The characteristics data included gender, age, burn area, cause of burns, body mass index, and intake analysis were obtained from medical records and were analyzed using Spearman’s correlation and linear regression.Result : A total of 68 subjects were included in this study. There was an increase in energy intake from day 1 to day 7 of 10.81 + 12.73 Kcal/kgBW. There was a significant negative weak correlation between energy changes from day-1 to day-7 and length of stay (r = -0.25, p = 0.03).Conclusion: The higher energy increases within 7 days of treatment, the shorter the LOS of burn patients. Further research is still needed to assess the components that influence nutrition intake and how they impact the clinical outcome of burn patients.
- 11 December 2024
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 9 (2) , 42-47
Open AccessIncreased Nutrition Intake from Day 1 to Day 7 and Its Correlation with LOS in The Burn Unit of Dr. Cipto Mangunkusumo Hospital Jakarta
Introduction : Burn patients as well as the critically ill experience strong oxidative stress, an intense inflammatory response, and a prolonged months-long hypermetabolic and catabolic response that affect nutritional requirements. This study aimed to investigate the nutrition intake in the acute phase from day 1 to day 7 and the correlation with length of stay (LOS) in burn patients in Dr. Cipto Mangunkusumo General Hospital.Method : This cross-sectional study was conducted from January to December 2020 in the Burn Unit of Dr. Cipto Mangunkusumo General Hospital. Research subjects were burns patients who were willing to take part in this research and met the research criteria. The characteristics data included gender, age, burn area, cause of burns, body mass index, and intake analysis were obtained from medical records and were analyzed using Spearman’s correlation and linear regression.Result : A total of 68 subjects were included in this study. There was an increase in energy intake from day 1 to day 7 of 10.81 + 12.73 Kcal/kgBW. There was a significant negative weak correlation between energy changes from day-1 to day-7 and length of stay (r = -0.25, p = 0.03).Conclusion: The higher energy increases within 7 days of treatment, the shorter the LOS of burn patients. Further research is still needed to assess the components that influence nutrition intake and how they impact the clinical outcome of burn patients.
- Open Access
- 11 December 2024
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 8 (2) , 84-87
Dietary Soluble Fiber Improved Fecal Consistency in Burned Patients with Diarrhea
Backgrounds: Diarrhea frequently occurs in severely burned patients attributable to impaired intestinal integrity and dysbiosis. Soluble fiber may improve intestinal barrier function, avoid bacterial translocation, then subsequently prevent and treat diarrhea. Soluble fiber is rapidly fermented by commensal bacteria and produces short-chain fatty acids (SCFA). Case Reports: A 51-year-old male with severe burn injury involving 53,5% total body surface area (TBSA) and diarrhea were given soluble fiber as part of his diet. Results: Administration of 6–10 g/d soluble fiber clinically improves stool consistency, assessed by Bristol Stool Scale, in the severely burned patient. The patient was discharged after 19 days of hospitalization with improvement in clinical condition. Summary: SCFA maintains intestinal integrity, supports the growth of commensal bacteria, and inhibits pathogens. There is no specific recommendation regarding fiber intake in burned patients
- 11 December 2024
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 8 (2) , 84-87
Open AccessDietary Soluble Fiber Improved Fecal Consistency in Burned Patients with Diarrhea
Backgrounds: Diarrhea frequently occurs in severely burned patients attributable to impaired intestinal integrity and dysbiosis. Soluble fiber may improve intestinal barrier function, avoid bacterial translocation, then subsequently prevent and treat diarrhea. Soluble fiber is rapidly fermented by commensal bacteria and produces short-chain fatty acids (SCFA). Case Reports: A 51-year-old male with severe burn injury involving 53,5% total body surface area (TBSA) and diarrhea were given soluble fiber as part of his diet. Results: Administration of 6–10 g/d soluble fiber clinically improves stool consistency, assessed by Bristol Stool Scale, in the severely burned patient. The patient was discharged after 19 days of hospitalization with improvement in clinical condition. Summary: SCFA maintains intestinal integrity, supports the growth of commensal bacteria, and inhibits pathogens. There is no specific recommendation regarding fiber intake in burned patients
- Open Access
- 31 October 2023
- Published by UPT Penerbitan Universitas Jember in Journal of Agromedicine and Medical Sciences
- Vol. 9 (3) , 110-117
Mortality Rates Of Adult Pulmonary Tuberculosis With Malnutrition: A Case Report And Comprehensive Literature Review
Tuberculosis (TB) and malnutrition are still major public health problems in the world. These two clinical conditions can occur simultaneously and create a vicious cycle that worsens TB infection or nutritional status. This case report aims to examine the relationship between low nutritional status (malnutrition) of patients and death due to pulmonary TB. A 31 year old woman came to the pulmonary clinic of a tertiary hospital in Jakarta for her third month of drug-sensitive anti-TB drug (OAT) treatment control. Three months earlier, the patient underwent a rapid diagnostic test (RDT) to determine OAT resistance. The conclusion of her anthropometric examination was body mass index (BMI) of 15.6 kg/m2. Before being diagnosed with pulmonary TB, she always had difficulty gaining weight. During the course of disease, her weight decreased by 5 kg per month. After undergoing treatment for 6 months, the patient was declared complete after 6 months of therapy, without any improvement in nutritional status. At 1 year follow-up, the patient experienced a relapse of pulmonary TB with a BMI of 13.2 kg/m2. She died 2 months after diagnosis of relapse TB. Improvement in clinical complaints and conversion to bacteriological examination are indications of successful therapy, including improvement in nutritional status. To analyze the relationship between malnutrition and pulmonary TB and death, the authors conducted a comprehensive literature search in the journal databases PubMed, Cochrane, and Scopus, followed by analysis according to the PRISMA 2020 flowchart, for a prognostic cohort study of cases of death in pulmonary TB patients with malnutrition. There is a relationship between BMI and the risk of death in TB patients. Anthropometric measurements, especially BMI, need to be carried out during every physical examination of pulmonary TB cases. Keywords: Body mass index; Malnutrition; Mortality; Tuberculosis
- 31 October 2023
- Published by UPT Penerbitan Universitas Jember in Journal of Agromedicine and Medical Sciences
- Vol. 9 (3) , 110-117
Open AccessMortality Rates Of Adult Pulmonary Tuberculosis With Malnutrition: A Case Report And Comprehensive Literature Review
Tuberculosis (TB) and malnutrition are still major public health problems in the world. These two clinical conditions can occur simultaneously and create a vicious cycle that worsens TB infection or nutritional status. This case report aims to examine the relationship between low nutritional status (malnutrition) of patients and death due to pulmonary TB. A 31 year old woman came to the pulmonary clinic of a tertiary hospital in Jakarta for her third month of drug-sensitive anti-TB drug (OAT) treatment control. Three months earlier, the patient underwent a rapid diagnostic test (RDT) to determine OAT resistance. The conclusion of her anthropometric examination was body mass index (BMI) of 15.6 kg/m2. Before being diagnosed with pulmonary TB, she always had difficulty gaining weight. During the course of disease, her weight decreased by 5 kg per month. After undergoing treatment for 6 months, the patient was declared complete after 6 months of therapy, without any improvement in nutritional status. At 1 year follow-up, the patient experienced a relapse of pulmonary TB with a BMI of 13.2 kg/m2. She died 2 months after diagnosis of relapse TB. Improvement in clinical complaints and conversion to bacteriological examination are indications of successful therapy, including improvement in nutritional status. To analyze the relationship between malnutrition and pulmonary TB and death, the authors conducted a comprehensive literature search in the journal databases PubMed, Cochrane, and Scopus, followed by analysis according to the PRISMA 2020 flowchart, for a prognostic cohort study of cases of death in pulmonary TB patients with malnutrition. There is a relationship between BMI and the risk of death in TB patients. Anthropometric measurements, especially BMI, need to be carried out during every physical examination of pulmonary TB cases. Keywords: Body mass index; Malnutrition; Mortality; Tuberculosis
- Open Access
- 31 May 2022
- Published by Indonesian Nutrition Association in World Nutrition Journal
- Vol. 5 (S3) , 36
Medical nutrition therapy and home monitoring in type 2 diabetes mellitus patient with metabolic syndrome and history of diabetic ketoacidosis
Obesity, one of the risk factors for mtype 2 diabetes mellitus (T2DM), is known to cause low-grade inflammation and increase T2DM morbidity. Obesity and T2DM also lead to other comorbidities, such as metabolic syndrome. The provision of medical nutrition therapy accompanied with routine home monitoring could improve glycemic control and achieve therapeutic targets, simultaneously.
- 31 May 2022
- Published by Indonesian Nutrition Association in World Nutrition Journal
- Vol. 5 (S3) , 36
Open AccessMedical nutrition therapy and home monitoring in type 2 diabetes mellitus patient with metabolic syndrome and history of diabetic ketoacidosis
Obesity, one of the risk factors for mtype 2 diabetes mellitus (T2DM), is known to cause low-grade inflammation and increase T2DM morbidity. Obesity and T2DM also lead to other comorbidities, such as metabolic syndrome. The provision of medical nutrition therapy accompanied with routine home monitoring could improve glycemic control and achieve therapeutic targets, simultaneously.
- Open Access
- 23 April 2021
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 8 (1) , 21-24
Nutrition Therapy in Type 2 Diabetic Burn Patient
Summary: Severe burn patients experience pronounced metabolic changes that caused hyperglycemia. Other existing metabolic conditions such as diabetes mellitus may worsen this condition. Early, adequate, and personalized nutrition therapy may result in better glycemic control and prognosis.A 44-year-old male with severe burn injury involving 27,5% total body surface area (TBSA) and type 2 diabetes mellitus (T2DM) was given early and diabetes-specific nutrition therapy to meet the recommended energy and protein needs. Lower carbohydrate contents and higher mono-unsaturated fatty acids (MUFA) were components of diabetes-specific nutrition therapy. Desirable blood glucose levels, a positive trend of albumin levels, and reduced inflammatory markers were achieved while being given this nutrition therapy. Sepsis was not diagnosed in this patient. The patient was discharged from the hospital after an improvement in clinical condition. Hyperglycemia commonly occurs in critically ill patients, especially with pre-existing T2DM. The provision of prompt and personalized nutrition therapy will improve clinical outcomes.
- 23 April 2021
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 8 (1) , 21-24
Open AccessNutrition Therapy in Type 2 Diabetic Burn Patient
Summary: Severe burn patients experience pronounced metabolic changes that caused hyperglycemia. Other existing metabolic conditions such as diabetes mellitus may worsen this condition. Early, adequate, and personalized nutrition therapy may result in better glycemic control and prognosis.A 44-year-old male with severe burn injury involving 27,5% total body surface area (TBSA) and type 2 diabetes mellitus (T2DM) was given early and diabetes-specific nutrition therapy to meet the recommended energy and protein needs. Lower carbohydrate contents and higher mono-unsaturated fatty acids (MUFA) were components of diabetes-specific nutrition therapy. Desirable blood glucose levels, a positive trend of albumin levels, and reduced inflammatory markers were achieved while being given this nutrition therapy. Sepsis was not diagnosed in this patient. The patient was discharged from the hospital after an improvement in clinical condition. Hyperglycemia commonly occurs in critically ill patients, especially with pre-existing T2DM. The provision of prompt and personalized nutrition therapy will improve clinical outcomes.
- 1 November 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 287-290
mHealth for Mother and Child Health Nutrition - A Review and Proposed Design for Indonesia Focus on Early Life Nutrition in Indonesia
Information and communication technologies (ICTs), such as computer, mobile phone, and internet, are emerged as an accelerator in the health sector development. They can play a critical role in pursuing outcome for most vulnerable groups, such as pregnant woman and children in developing countries. In this paper, we review the use of m-Health to improve mother and child health. We use the result of this review to propose a design for a set of m-Health applications focused on the improvement of mother and child nutrition in Indonesia. Our analysis of existing applications includes both a literature review and an empirical search of publicly available mobile apps from Google Search, Google Play, and Apple Store. From the review, we found that there exist several mobile and or e-Health systems focusing in improving early life nutrition delivery, both state and privately made. In Indonesia specifically, the Minister of Health has launched a mobile app for early life to work in conjunction an established monitoring book of mother and child health “Buku Kesehatan Ibu dan Anak”. However, the download rate of this app remains low. This result produced important information that can be further learned, so we could set and deliver a successful humanitarian technology implementation in improving early life nutrition care in Indonesia.
- 1 November 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 287-290
mHealth for Mother and Child Health Nutrition - A Review and Proposed Design for Indonesia Focus on Early Life Nutrition in Indonesia
Information and communication technologies (ICTs), such as computer, mobile phone, and internet, are emerged as an accelerator in the health sector development. They can play a critical role in pursuing outcome for most vulnerable groups, such as pregnant woman and children in developing countries. In this paper, we review the use of m-Health to improve mother and child health. We use the result of this review to propose a design for a set of m-Health applications focused on the improvement of mother and child nutrition in Indonesia. Our analysis of existing applications includes both a literature review and an empirical search of publicly available mobile apps from Google Search, Google Play, and Apple Store. From the review, we found that there exist several mobile and or e-Health systems focusing in improving early life nutrition delivery, both state and privately made. In Indonesia specifically, the Minister of Health has launched a mobile app for early life to work in conjunction an established monitoring book of mother and child health “Buku Kesehatan Ibu dan Anak”. However, the download rate of this app remains low. This result produced important information that can be further learned, so we could set and deliver a successful humanitarian technology implementation in improving early life nutrition care in Indonesia.